New board member announced--President and CEO of Avenir Capital.
"Response Biomedical Appoints Avenir Capital President, Rick Grafton, To Board Of Directors
VANCOUVER, BRITISH COLUMBIA--Response Biomedical Corp. (RBM:CDNX) today announced the appointment of Rick Grafton, President & CEO of Avenir Capital Corporation, to the Company's Board of Directors. Mr. Grafton has over 20 years of investment experience and has been instrumental in the financing of early-stage companies that have developed into solid, high growth businesses. Prior to Avenir, Mr. Grafton was a founding partner of FirstEnergy Capital Corporation, one of the leading energy investment firms in Canada.
"Mr. Grafton commented, ``I am looking forward to working with management and the Board in delivering on the Company's corporate strategy and ensuring a solid financial foundation as we approach numerous key milestones.''
"Additionally, the Company announced that, effective immediately, George Grafton has resigned his position on the Board of Directors.
``Rick's financial expertise and extensive network of financial professionals is a tremendous addition to our current capabilities,'' said John Hayes, interim Chairman of Response Biomedical's Board of Directors. ``I would like to thank George Grafton for his contribution to the Board and wish him continued success.''
"Response Biomedical develops quantitative, point-of-care, diagnostic tests for use with its proprietary RAMP System. The RAMP System reduces the cost of healthcare by allowing accurate, rapid and easy-to-use tests to be performed in hospitals, clinics, laboratories and physicians offices worldwide.
"The Canadian Venture Exchange has not reviewed and does not accept responsibility for the adequacy of the content of the information contained herein. The statements made in this press release may contain certain forward-looking statements that involve a number of risks and uncertainties. Actual events or results may differ from the Company's expectations." |
